KRT8P49

Across TCGA pan-cancer cohorts, KRT8P49 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated KRT8P49 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher KRT8P49 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated KRT8P49 expression acts as an unfavorable survival marker, although some lineages such as PRAD and COAD show a favorable association.

LUAD, PAAD, and OV are the cancer types where KRT8P49 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	All	0.736	0.859	<.001	75	view →
PAAD	OS	Quartile	All	0.514	0.768	<.001	55	view →
OV	DFS	Median	III,IV	0.330	0.409	.015	32	view →
MESO	OS	Quartile	III,IV	0.363	0.744	.004	25	view →
PRAD	DFS	Tertile	All	0.930	0.829	.001	16	view →
ESCA	OS	Median	All	0.647	1.000	.015	12	view →
DLBC	OS	Tertile	III,IV	0.272	1.000	.038	9	view →
COAD	OS	Quartile	III,IV	0.869	0.695	.019	9	view →
LUSC	OS	Quartile	All	0.717	0.559	.005	9	view →
LIHC	DFS	Quartile	All	0.345	0.599	.005	9	view →
TGCT	OS	Median	All	0.923	1.000	.037	6	view →
BRCA	OS	Quartile	III,IV	0.949	0.858	.015	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

KRT8P49–LUAD (OS)

Open the LUAD breakdown →